e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Non-inflammatory monitoring of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gender differences of echocardiographic characteristics in patients with acute exacerbation of COPD
Krishna K Sharma (Jaipur, Rajastahan, India), Krishna K. Sharma, Hemant Chaturvedi, Rudra Dev Pandey, Titiksha Choyal
Source:
International Congress 2015 – Non-inflammatory monitoring of airway diseases
Session:
Non-inflammatory monitoring of airway diseases
Session type:
Thematic Poster Session
Number:
2527
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Krishna K Sharma (Jaipur, Rajastahan, India), Krishna K. Sharma, Hemant Chaturvedi, Rudra Dev Pandey, Titiksha Choyal. Gender differences of echocardiographic characteristics in patients with acute exacerbation of COPD. Eur Respir J 2015; 46: Suppl. 59, 2527
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
The frequency of COPD exacerbations is related to the comorbidity profile
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Changes in cognitive status during acute exacerbation of COPD
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015
Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
One-year mortality in COPD patients after severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014
Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure
Source: International Congress 2014 – Markers
Year: 2014
COPD exacerbation admissions: Analysis of demographics and mortality
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept